Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics

The antibiotic linezolid, the first clinically approved member of the oxazolidinone class, inhibits translation of bacterial ribosomes by binding to the peptidyl transferase center. Recent work has demonstrated that linezolid does not inhibit peptide bond formation at all sequences but rather acts in a context-specific manner, namely when alanine occupies the penultimate position of the nascent chain. However, the molecular basis for context-specificity has not been elucidated. Here we show that the second-generation oxazolidinone radezolid also induces stalling with a penultimate alanine, and we determine high-resolution cryo-EM structures of linezolid- and radezolid-stalled ribosome complexes to explain their mechanism of action. These structures reveal that the alanine side chain fits within a small hydrophobic crevice created by oxazolidinone, resulting in improved ribosome binding. Modification of the ribosome by the antibiotic resistance enzyme Cfr disrupts stalling due to repositioning of the modified nucleotide. Together, our findings provide molecular understanding for the context-specificity of oxazolidinones. The authors determine the cryo-EM structures of prokaryotic ribosomes with the oxazolidinone antibiotics linezolid and radezolid bound to the peptidyl transferase center with an adjacent growing nascent peptide chain, providing an explanation for their context-specific action.

Automated summary

Linezolid and radezolid are oxazolidinone antibiotics that inhibit bacterial ribosome translation by binding to the peptidyl transferase center in a context-specific manner, leading to stalling when alanine occupies the penultimate position in the nascent chain.